摘要 |
This invention discloses furo-pyrimidine compounds, and pharmaceutically acceptable salts thereof, useful in therapeutically and/or prophylactically treating patients with an illness. Such illnesses include cancer, and secondary infections caused by Pneumocystis carinii and Toxoplasmosis gondii in immunocompromised patients. The furo-pyrimidine compounds themselves, methods of making these compounds, and methods of using these furo-pyrimidine compounds are all disclosed.
|